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Taxanes (paclitaxel and docetaxel) are antimicrotubule agents used in the clinical 
practice for the treatment of solid tumors. The molecular mechanisms of taxane-	
dependent cytotoxicity are only partially known. In vitro, different modes of action have 
been established for paclitaxel according to its concentration. A similar phenomenon 
has been shown for other microtubule-stabilizing drugs, including docetaxel. Recently, 
we described two different forms of mitotic exit in breast cancer cell lines exposed to 
docetaxel. The causes and consequences of the dual mechanism of cytotoxicity of this 
agent are discussed here.
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Most	 studies,	 especially	 with	 paclitaxel,	 have	 shown	 cell	 cycle	 arrest	 in	mitosis	 as	 a	
necessary	step	for	cell	death.	However,	it	is	also	necessary	that	cells	overcome	this	arrest,	
advancing	 to	 interphase	 without	 cytokinesis	 (a	 process	 called	 mitotic	 slippage),	 and	
entering	a	 tetraploid	or	“pseudo-G1”	phase	 followed	by	apoptotic	cell	death.
5,6	Mitotic	






Several	 questions	 still	 remain	 to	 be	 answered	 regarding	 the	 mechanisms	 of	 taxane-	
dependent	 cytotoxicity	 in	 tumor	 cells,	 including	 the	 induction	 of	 cell	 death	 without	
mitotic	 arrest	 in	 some	 experimental	 conditions,	 the	 dependence	 of	 these	 processes	 on	
transcriptional	mechanisms,	 the	 importance	of	 a	 functional	p53	protein,	 and	 the	 exact	
mechanism(s)	by	which	tumor	cells	die.





performed	 after	 two	 concentrations	 of	 docetaxel.	 The	 most	 striking	 differences	 were	
found	at	the	 level	of	cell	cycle.	Low	concentrations	(2–4	nM)	induced	aberrant	mitosis	






















nism	 of	 action	 of	 taxanes	 had	 been	 reported	 with	 paclitaxel.12-15	
In	 accordance	 to	 our	 findings	 with	 docetaxel,	 Ikui	 et	 al	 reported	
that	higher	 concentrations	of	paclitaxel	 induce	 a	 longer	 spindle-as-
sembly	 checkpoint	 in	 HeLa	 cells.	 In	 contrast,	 low	 concentrations	
of	paclitaxel	cause	mitotic	delay	followed	by	premature	dissociation	








affect	 the	 dynamics	 of	microtubules,	 inducing	 a	 transient	 activation	
of	 the	 spindle-assembly	 checkpoint.	 In	 the	 breast	 cancer	 cells	 that	
we	 evaluated,	 this	 checkpoint	 is	 not	 strong	 enough	 to	 stop	 the	
segregation	of	chromosomes,	and	this	is	manifested	by	aneuploidy.17	
Aneuploidy	is	known	to	be	the	result	of	aberrant	mitosis	which	can	
be	 caused	 by	 divisions	 in	 the	 presence	 of	 a	multipolar	 spindle,	 as	
has	been	described	for	docetaxel.	However,	 it	can	also	be	the	result	
of	 previous	 defects	 in	 cytokinesis	 or	 centrosome	 amplification,	 by	
defects	 in	chromosome	cohesion,	by	spindle	attachment	defects,	or	




after	passing	 through	mitosis.	This	 suggests	 that	mechanisms	 inde-
pendent	of	centrosome	duplication	are	related	with	the	induction	of	
aberrant	mitosis	in	this	context.
Our	gene	expression	data	 supports	 some	of	 these	previous	 find-
ings.	Favoring	the	stronger	mitotic	arrest	with	higher	concentrations	
of	docetaxel,	an	induction	of	mitosis-related	genes	(AURKA, PLK1)	
was	 observed	 in	 this	 condition	 (Fig.	 2).	 Checkpoint-related	 genes	








Figure 1. Exit from mitosis after exposure to docetaxel. The effect of docetaxel 
on cell cycle is represented here after a synchronization experiment. Cells 
normally replicating their DNA from G1 (2n) to G2 (4n) are then subjected 
to low and high concentrations of the drug. Cells not receiving treatment exit 
normal mitosis (M) to start a new cell cycle from G1 (1). In contrast, low and 
high concentrations of docetaxel induce transient (3) or prolonged (2) arrest 
in mitosis, respectively. The respective cell cycle profiles (obtained by DNA 
staining with propidium iodide) are shown.
Figure 2. Transcriptional responses to docetaxel. Gene expression profiles 
of selected transcripts after treatment of MCF7 cells with 2 concentrations 
of docetaxel (4 nM and 100 nM), and different time points (8, 24 and 



















taxane	exposure.	 In	 support	of	 this	view,	 the	 results	of	Chen	et	 al.	
suggest	that	the	mitotic	slippage	induced	by	microtubule-stabilizing	
drugs	 may	 result	 from	 altered	 transcriptional	 regulation	 of	 G2/M	
and	 spindle	 checkpoint	 genes	when	 higher	 concentrations	 of	 drug	
are	 used.15	 Finally,	 we	 observed	 a	 different	 expression	 profile	 of	
known	 p53	 targets	 when	 comparing	 low	 and	 high	 concentrations	




(Figs.	 2	 and	 3).	This	 observation	 supports	 a	model	 in	 which	 p53	
protein	accumulation	 is	a	marker	of	 the	 timing	of	mitotic	arrest.18	
In	addition,	the	earlier	induction	of	p21	after	low	concentrations	of	
docetaxel	may	 be	 related	with	 the	mechanism	 of	 aberrant	mitosis,	
as	 has	 been	 reported.19	 In	 fact,	 previous	 studies	 have	 suggested	
that	p21	 is	not	required	 for	 the	mitotic	arrest	 in	response	 to	pacli-
taxel,	 but	 instead	 it	 could	 have	 a	 role	 in	 facilitating	 the	 exit	 from	
abnormal	mitosis.20
Together,	these	data	point	to	a	mechanism	regulating	the	different	
consequences	 of	 docetaxel	 exposure	 according	 to	 the	 duration	 of	
mitotic	 arrest.	 This	 mechanism	 can	 be	 partially	 regulated	 at	 the	
transcriptional	level	by	changes	both	in	p21	and	checkpoint	genes.
A duAl MecHAnisM iMPlies duAl outcoMes
Induction	of	apoptosis	has	been	described	as	a	main	mechanism	
of	 cell	 death	 after	 antimicrotubule	 agents,	 implicating	 different	
downstream	events	 including	 the	dysregulation	of	 cell	 cycle-related	
proteins	(particularly	p34cdc-2),21	the	activation	of	the	jun	N-terminal	




induced	 a	 clear	 pattern	 of	 early	 apoptosis	 by	 Annexin-V	 staining	






after	 taxane	 therapy.31	More	 recently,	 it	was	 shown	that	autophagy	
can	be	an	important	form	of	programmed	cell	death	after	treatment	
of	MCF7	breast	 cancer	 cells	with	paclitaxel	 analogs	 and	docetaxel,	
by	 using	MAP	 I	 LC3	 antibody	 as	 an	 specific	marker	 of	 autopha-
gosomes.32	Therefore,	 the	most	 likely	 scenery	 is	 a	 combination	 of	
apoptotic	and	nonapoptotic	mechanisms.	In	fact,	a	known	mediator	
of	 apoptosis	 after	 taxane	 therapy	 is	 the	 cell	 death	 receptor	CD95/




mitosis	 induced	 by	 low	 concentrations	 of	 docetaxel.	 One	 possible	
mechanism	triggering	cell	death	 in	 this	 context	 is	 the	 induction	of	
DNA	damage.	It	is	likely	that	aberrant	mitosis	creates	chromosomal	
breakage,	 interchromosomal	 concatenation	 and	 a	 lethal	 genetic	
imbalance	that	leads	to	cell	death.5,33	In	this	sense,	we	have	observed	
accumulation	 of	 phospho-H2AX	 after	 docetaxel,	 especially	 in	 the	
















Figure 3. Model of cell outcome according to drug concentration. A model 
for the dual mechanism of action of docetaxel is represented in the diagram. 
The main effects and outcomes are shown in a color gradient, corresponding to 
the increasing concentrations of the drug. The hypothetic correlation between 
induction of the spindle-assembly checkpoint (S-A-checkpoint) and accumula-
tion of p53 protein is shown, as well as the inverse correlation between p53, 
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